Abstract:(Cell Stem Cell 4, 16–19; January 9, 2009) In our recent article, we unfortunately misquoted the findings in a recent study by Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar. When describing previous work using combination of the MEK inhibitor PD0325901 and the GSK3b inhibitor CHIR99021, our statement “Recent studies demonstrated that addition of the FGFR inhibitor PD173074 to the above cocktail is sufficient to maintain mESC pluripotency in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar).” was not accurate. Ying et al., in fact, used PD0325901 to replace PD1730474 and demonstrated maintenance of mESCs in the absence of LIF with these two factors only. The corrected section reads “Indeed, after serial passages, the growth of putative riPSCs treated with only PD0325901 and CHIR99021 declined, and the culture deteriorated due to the expansion of differentiated cells, although recent studies demonstrated that this combination of inhibitors can be used to maintain mESC self-renewal in the absence of LIF (Ying et al., 2008Ying Q.-L. Wray J. Nichols J. Batlle-Morera L. Doble B. Woodgett J. Cohen P. Smith A. The ground state of embryonic stem cell self-renewal.Nature. 2008; 453: 519-523Crossref PubMed Scopus (2530) Google Scholar). Because the TGFβ/Activin A/Nodal signaling cascade is essential to maintain undifferentiated hESCs and EpiSCs, but dispensable for mESC self-renewal, we tested whether the addition of an inhibitor of the type 1 TGFβ receptor, ALK5 (A-83-01), could help stabilize our riPSC cultures.” In addition, we omitted to mention that while our study was under review, Silva et al., 2008Silva J. Barrandon O. Nichols J. Kawaguchi J. Theunissen T.W. Smith A. Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition.PLoS Biol. 2008; 6: 2237-2247https://doi.org/10.1371/journal.pbio.0060253Crossref Scopus (651) Google Scholar also published the use of these two inhibitors in the generation and propagation of mouse iPSCs. We apologize for any confusion caused. Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical InhibitorsLi et al.Cell Stem CellDecember 18, 2008In BriefConventional mouse and human embryonic stem cells (ESCs) can be typically derived by in vitro culture of blastocysts (Martin, 1981; Thomson et al., 1998), and induced pluripotent stem cells (iPSCs) can be generated by reprogramming somatic cells using defined genetic transduction methods (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). In both cases, different signaling pathways appear to regulate pluripotency with different characteristics in the two species. However, while rat ESC-like cells have been established based on certain traits (Demers et al., 2007; Ruhnke et al., 2003; Schulze et al., 2006; Ueda et al., 2008), to date, these lines fall short of exhibiting true pluripotency (e.g., fail to form teratoma or no/little contribution to chimerism) and thus cannot be considered authentic rat ESCs. Full-Text PDF Open Archive

Mouse totipotent stem cells captured and maintained through spliceosomal repression

Comparative Analyses of Single-Cell Transcriptomic Profiles between In Vitro Totipotent Blastomere-like Cells and In Vivo Early Mouse Embryonic Cells

Lysosomal Catabolic Activity Promotes the Exit of Murine Totipotent 2-Cell State by Silencing Early-Embryonic Retrotransposons

Capturing totipotency in human cells through spliceosomal repression

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Efficient Reprogramming of Mouse Embryonic Stem Cells into Trophoblast Stem-like Cells via Lats Kinase Inhibition

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors

Derivation of totipotent-like stem cells with blastocyst-like structure forming potential

Rolling back human pluripotent stem cells to an eight-cell embryo-like stage

Induction of mouse totipotent stem cells by a defined chemical cocktail

Locus-Specific Isolation of the Nanog Chromatin Identifies Regulators Relevant to Pluripotency of Mouse Embryonic Stem Cells and Reprogramming of Somatic Cells

A Conserved Role of Shp2 in Regulation of Human and Mouse Es Cell Differentiation

Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors

Relaxed 3D genome conformation facilitates the pluripotent to totipotent-like state transition in embryonic stem cells

A Genome-Wide CRISPR Screen Identifies Factors Regulating Pluripotency Exit in Mouse Embryonic Stem Cells

The totipotent 2C‐like state safeguards genomic stability of mouse embryonic stem cells

A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells.

Epigenetic reprogramming in the transition from pluripotency to totipotency

Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells

Relaxed 3D Genome Conformation Facilitates the Pluripotent to Totipotent State Transition in Embryonic Stem Cells